<DOC>
	<DOCNO>NCT00989989</DOCNO>
	<brief_summary>This study design confirm efficacy safety ranibizumab ( 0.5 mg ) adjunctive therapy add laser photocoagulation and/or monotherapy Asian patient visual impairment due Diabetic Macular Edema ( DME ) .</brief_summary>
	<brief_title>Efficacy Safety Ranibizumab ( Intravitreal Injections ) Patients With Visual Impairment Due Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Vision Disorders</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Patients Type 1 Type 2 diabetes mellitus accord American Diabetes Association ( ADA ) World Health Organization ( WHO ) guideline HbA1c 10.0 % screening ( Visit 1 ) . Patients diet , exercise , and/or pharmacological treatment diabetes . Patients visual impairment due focal diffuse Diabetic Macular Edema least one eye eligible laser treatment opinion investigator . If eye eligible , one bad visual acuity , assess Visit 1 , select study treatment unless , base medical reason , investigator deems eye appropriate candidate study treatment . The study eye must fulfill follow criterion Visit 1 : BestCorrected Visual Acuity ( BCVA ) score 78 39 letter , inclusively , use Early Treatment Diabetic Retinopathy ( ETDRS ) chartlike visual acuity test chart test distance 4 meter ( approximate Snellen equivalent 20/32 20/160 ) . Decrease vision due DME due cause , opinion investigator . Medication management diabetes must stable within 3 month prior randomization expect remain stable course study . Ocular concomitant conditions/ disease : Concomitant condition study eye could , opinion investigator , prevent improvement visual acuity study treatment . Active intraocular inflammation either eye . Any active infection either eye . History uveitis either eye . Uncontrolled glaucoma either eye . Ocular treatment : Panretinal laser photocoagulation study eye within 6 month prior study . Focal/grid laser photocoagulation study eye within 3 month prior study entry . Systemic condition treatment : History stroke Renal failure require dialysis renal transplant renal insufficiency creatinine level &gt; 2.0 mg/dL . Untreated diabetes mellitus Blood pressure systolic &gt; 160 mmHg diastolic &gt; 100 mmHg Compliance/ Administrative : Pregnant nursing ( lactate ) woman Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>DME</keyword>
	<keyword>Diabetic</keyword>
	<keyword>macula</keyword>
	<keyword>edema</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>REVEAL</keyword>
</DOC>